| 26586345 |
Encorafenib (LGX818), a potent BRAF inhibitor, induces senescence accompanied by autophagy in BRAFV600E melanoma cells
Gong, P,
Liu, J,
Zhao, Y,
Zhu, X,
Song, Z,
Bi, X,
Meng, S,
Song, F,
Piao, Y,
Lin, G,
Cheng, W,
Jiang, K,
Li, Z
|
Cancer Lett. |
2016 |
| 28611198 |
Phase I Dose-Escalation and -Expansion Study of the BRAF Inhibitor Encorafenib (LGX818) in Metastatic BRAF-Mutant Melanoma
Moutouh-de Parseval, L,
Stuart, DD,
Demuth, T,
Sullivan, R,
Carlino, MS,
Kefford, RF,
Gomez-Roca, C,
McArthur, GA,
Delord, JP,
Yamada, Y,
Kudchakar, R,
Michel, D,
Mahipal, A,
Robert, C,
Caponigro, G,
Aslanis, V,
Dummer, R,
Seroutou, A,
Arance, A,
Nyakas, M,
Hidalgo, M
|
Clin. Cancer Res. |
2017 |
